TURKISH JOURNAL OF HEMATOLOGY, vol.37, no.3, pp.139-144, 2020 (Peer-Reviewed Journal)
Article / Article
TURKISH JOURNAL OF HEMATOLOGY
Science Citation Index Expanded, Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
Immune thrombocytopenia, Eltrombopag, Iron deficiency, QUALITY-OF-LIFE, DOUBLE-BLIND, THROMBOPOIETIN, ROMIPLOSTIM, ADULTS
Objective: Immune thrombocytopenia (ITP) is a rare autoimmune disease and hematologic disorder characterized by reduced platelet counts that can result in significant symptoms, such as bleeding, bruising, epistaxis, or petechiae. The thrombopoietin receptor agonist eltrombopag (EPAG) is a second-line agent used to treat chronic ITP purpura in adults and children.